Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine
about
Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccinePhase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.Delivery of foreign antigens by engineered outer membrane vesicle vaccines.Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines.Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens.Cellular Immune Responses in Humans Induced by Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines Given Separately and in CombinationGlycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial VaccinesShort-term and long-term antibody response by mice after immunization against Neisseria meningitidis B or diphtheria toxoid.Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future.New versus old meningococcal group B vaccines: how the new ones may benefit infants & toddlers.Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.Naturally produced outer membrane vesicles from Pseudomonas aeruginosa elicit a potent innate immune response via combined sensing of both lipopolysaccharide and protein components.Population coverage analysis of T-Cell epitopes of Neisseria meningitidis serogroup B from Iron acquisition proteins for vaccine design.Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection.Vaccination strategies for the prevention of meningococcal disease.
P2860
Q28749695-C72C17A7-DBA2-456D-BCA4-1B89DD0F861DQ30227840-0315ADE5-654F-4B32-B216-ACDE530625AFQ33733590-5ACBA7AF-EEAB-446E-8977-3846BF90F1DAQ36095135-01F50ECD-858F-4D43-BBAF-F84ADE698FCCQ36313603-28573871-ACD7-4F0B-A6ED-D5DC9E28F19EQ36764403-1A640606-6DF9-438A-AD52-53B4A58FECA2Q36823959-527076FA-71D8-45BE-A2DC-0D5AE530889CQ37371372-F9A0928C-1E07-42B4-BB4E-03B7F3500A86Q37514748-249B0B54-9BFA-4747-B33F-9B0CB538BB78Q37690815-57CAC701-34F8-4B38-93FF-750D57FCE1B1Q37798011-C685DD33-743F-4F2D-A53A-8676B2DFE619Q42181392-141EF716-08B7-4DF1-BA1B-733365D3E58CQ42776796-F7F0DF97-3A8C-42D7-8620-36FDA5368CE6Q48138824-9A8D6546-1EFE-4E19-8467-DBD44E635869Q54964676-BE9DE9C2-250C-452A-A79C-87E21A229FB1
P2860
Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Persisting immune responses in ...... outer membrane vesicle vaccine
@ast
Persisting immune responses in ...... outer membrane vesicle vaccine
@en
Persisting immune responses in ...... outer membrane vesicle vaccine
@nl
type
label
Persisting immune responses in ...... outer membrane vesicle vaccine
@ast
Persisting immune responses in ...... outer membrane vesicle vaccine
@en
Persisting immune responses in ...... outer membrane vesicle vaccine
@nl
prefLabel
Persisting immune responses in ...... outer membrane vesicle vaccine
@ast
Persisting immune responses in ...... outer membrane vesicle vaccine
@en
Persisting immune responses in ...... outer membrane vesicle vaccine
@nl
P2093
P2860
P356
P1476
Persisting immune responses in ...... outer membrane vesicle vaccine
@en
P2093
Berit Feiring
Einar Rosenqvist
Ingeborg S Aaberge
Jan Fuglesang
Lisbeth M Naess
Marianne A R Bergsaker
Oddveig S Helland
Philipp Oster
Sandrine Tilman
P2860
P304
P356
10.1128/CVI.00047-06
P577
2006-07-01T00:00:00Z